Evidence map›Paper›PMID 36465675›Full record

ArticleRoyal Society open science2022

A self-purifying microfluidic system for identifying drugs acting against adult schistosomes.

Vincent Girod, Robin Houssier, Karin Sahmer, Marie-José Ghoris, Stéphanie Caby, Oleg Melnyk, Colette Dissous, Vincent Senez, Jérôme Vicogne

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Royal Society open science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Vincent GirodUniversity of Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille F-59000, France.
Robin HoussierUniversity of Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille F-59000, France.
Karin SahmerUniversity of Lille, IMT Lille Douai, University of Artois, JUNIA, ULR 4515 - LGCgE, Laboratoire de Génie Civil et géo-Environnement, F-59000 Lille, France.
Marie-José GhorisUniversity of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017 - Center for Infection and Immunity of Lille, F-59000 Lille, France.
Stéphanie CabyUniversity of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017 - Center for Infection and Immunity of Lille, F-59000 Lille, France.
Oleg MelnykUniversity of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017 - Center for Infection and Immunity of Lille, F-59000 Lille, France.
Colette DissousUniversity of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017 - Center for Infection and Immunity of Lille, F-59000 Lille, France.
Vincent SenezUniversity of Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille F-59000, France.
Jérôme VicogneUniversity of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017 - Center for Infection and Immunity of Lille, F-59000 Lille, France.ORCID 0000-0001-8360-7497
Centre National de la Recherche Scientifique · FRUniversité de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The discovery of novel antihelmintic molecules to combat the development and spread of schistosomiasis, a disease caused by several

Indexed as

drug screeningmedia optimizationmicrofluidsparasiteschistosomiasiswhole worms

Identifiers

PMID36465675
PMCPMC9709518
OpenAlexW4310474805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.